Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tripputi

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Recenti Progressi in Medicina|January 1, 1994
[Multiple myeloma. Role of prognostic factors and staging in a therapeutic program]S Bolis, E R Bregani, F Rossini, et al.
Clinical Drug Investigation|March 29, 2008
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic OutcomesF Rossini, P Pioltelli, S Bolis, et al.
American Journal of Human Genetics|March 1, 1992
Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2A D Børglum, A Byskov, P Ragno, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1984
A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemiaA I Dayton, J R Selden, G Laws, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Recenti Progressi in Medicina|January 1, 1994
[Multiple myeloma. Role of prognostic factors and staging in a therapeutic program]S Bolis, E R Bregani, F Rossini, et al.
Clinical Drug Investigation|March 29, 2008
Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic OutcomesF Rossini, P Pioltelli, S Bolis, et al.
American Journal of Human Genetics|March 1, 1992
Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2A D Børglum, A Byskov, P Ragno, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1984
A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemiaA I Dayton, J R Selden, G Laws, et al.
Pageof 3